Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study

NCT ID: NCT00552136

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-30

Study Completion Date

2030-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the clinical outcome success rate of Total Ankle Arthroplasty is similar to that of Ankle Arthrodesis over a period of 10 years. This will include looking at whether Total ankle arthroplasty results in a lower rate of hindfoot arthrosis and arthritis after surgery compared to ankle joint arthrodesis and if the rate of complications and revision surgery is acceptable when compared to Ankle Arthrodesis over a period of 10 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ankle Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ankle Arthroplasty

Group Type ACTIVE_COMPARATOR

Ankle Arthroplasty

Intervention Type PROCEDURE

Ankle Artrodeses

Group Type ACTIVE_COMPARATOR

Ankle Arthrodesis

Intervention Type PROCEDURE

Ankle fusion surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ankle Arthroplasty

Intervention Type PROCEDURE

Ankle Arthrodesis

Ankle fusion surgery

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Replacement Fusion

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eighteen (18) or older
* Known to have ankle arthritis for more than six (6) months
* Tried non operative treatment measures (eg. activity modification, physiotherapy, orthotics, bracing etc.) and have not improved
* Patient tests (questionnaires) show that ankle arthritis is severe
* Patient willing to take part in the study, including signing consent form after carefully reading it

Exclusion Criteria

* Dead Bone in the Ankle
* Severe foot or Ankle Deformity
* Prior Ankle Fusion or Replacement
* Active or Prior Infection in the Ankle
* Obesity (greater than 250 lbs)
* Medical Conditions precluding safe surgery
* Nerve or Muscle disease
* Severe osteoporosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Orthopaedic Foot and Ankle Society

OTHER

Sponsor Role collaborator

Johnson & Johnson

INDUSTRY

Sponsor Role collaborator

Nova Scotia Health Authority

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Glazebrook, MD

Role: PRINCIPAL_INVESTIGATOR

Capital District Health Authority, Halifax Canada

Tim Daniels, MD

Role: PRINCIPAL_INVESTIGATOR

St. Michael's Hospital (Toronto, Canada)

Alistair Younger, MD

Role: PRINCIPAL_INVESTIGATOR

British Columbia Canada

Johnny Lau, MD

Role: PRINCIPAL_INVESTIGATOR

TorontoWestern Hospital, Toronto Canada

Peter Dryden, MD

Role: PRINCIPAL_INVESTIGATOR

Victoria, British Columbia Canada

Murry Penner, MD

Role: PRINCIPAL_INVESTIGATOR

British Columbia,Canada

Kevin Wing, MD

Role: PRINCIPAL_INVESTIGATOR

British Columbia, Canada

Craig Stone, MD

Role: PRINCIPAL_INVESTIGATOR

Newfoundland, Canada

Dave Stevens, MD

Role: PRINCIPAL_INVESTIGATOR

Waterloo, Ontario Canada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

QEII Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDHA-MG-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Total Ankle Replacement Versus Arthrodesis Trial
NCT02128555 ACTIVE_NOT_RECRUITING NA
Comparing Ankle Fusion to Ankle Replacement
NCT01620541 ACTIVE_NOT_RECRUITING
Ankle Osteoarthritis
NCT03157141 UNKNOWN
Incidence of Adductor Canal Catheter Dislodgment
NCT05961085 ACTIVE_NOT_RECRUITING